CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Nightstar Therapeutics PLC is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Nightstar Therapeutics PLC
9-10 Midford Place
Phone: +44 2076112077p:+44 2076112077 LONDON, MA  W1T 5BJ  United Kingdom
This company was Merged or Acquired on 6/7/2019.
This company ceased filing statements with the SEC on 6/17/2019.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company
Business Summary
Nightstar Therapeutics Ltd is a United Kingdom-based company, which is a clinical-stage gene therapy company that focused on developing and commercializing novel one-time treatments for patients suffering from rare inherited retinal diseases. It is focused on adeno-associated virus (AAV) treatments for inherited retinal disorders.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/201912/31/2018YesYes---

Industries
SIC Code Description
8731 Commercial physical and biological research
2836 Biological products, except diagnostic substances

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer & Director DavidFellows
Chief Financial Officer SenthilSundaram
Chief Development Officer TuyenOng
7 additional Officers and Directors records available in full report.

Business Names
Business Name
Nightstar Europa Limited
Nightstar, Inc.
NightstaRx Limited
NITE

General Information
Number of Employees: 47 (As of 12/31/2018)
Outstanding Shares: 33,536,214 (As of 4/24/2019)
Shareholders: 7
Stock Exchange: NASD


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023